This article was originally published in The Rose Sheet
Executive SummaryPerfumes and cosmetics division sales increased 6.5% to $663 mil. (€1=$1.31) in Q1, driven by Parfums Christian Dior, which benefited from the success of Pure Poison fragrance, and BeneFit, which achieved double-digit sales growth in dollar terms, LVMH announces April 20. Guerlain also maintained "renewed momentum" due to the success of its L'Instant scent and makeup offerings, company adds. In addition, Sephora achieved double-digit sales growth on a comparable store basis in the U.S., and gained market share in Europe. LVMH's overall sales grew 9.8% on a reported bases to $4.04 bil. during the quarter, an 11% increase at constant exchange rates...
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.